CYP11B2 and adrenal cortex carcinoma: Overexpression of CASZ1 reduces aldosterone synthase (CYP11B2) and aldosterone levels in adrenocortical carcinoma cells (H295R-S2), suggesting that it probably inhibits CYP11B2 expression and the consequential aldosterone synthesis [9].